Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lancet iron study

This article was originally published in The Tan Sheet

Executive Summary

"Current guidelines for universal supplementation with iron and folic acid should be revised" because "routine supplementation with iron and folic acid in preschool children in a population with high rates of malaria can result in an increased risk of severe illness and death," according to a study published in The Lancet Jan. 14. Sunil Sazawaal, Johns Hopkins University, et al., conducted an 18-month randomized, double-masked, placebo-controlled trial in Pemba, Zanzibar on children aged one month to 4 years. "Midway through the trial, the iron and folic acid-containing groups had to be stopped because they were associated with higher rates of adverse events (hospital admissions and deaths) than the zinc and placebo groups," the authors state. International guidelines currently recommend supplementation in children younger than two-years-old who live in areas with a high prevalence of anemia, Sazawaal et al. note...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel